Agilent Technologies Inc and WiCell, a leader in the cytogenetic testing of mouse and human embryonic stem cells and induced pluripotent stem cells, have announced that WiCell is now offering comparative genomic hybridization plus single nucleotide polymorphism microarray analysis using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.
Showing posts with label Agilent Technologies. Show all posts
Showing posts with label Agilent Technologies. Show all posts
Tuesday, 4 December 2012
Wednesday, 2 March 2011
Independent survey ranks Agilent Technologies No 1 partner for laboratory standards compliance
Agilent Technologies Inctoday announced that a recent independent survey once again named Agilent as the preferred partner for laboratories that must measure up to regulatory and quality standards. More than 350 survey respondents in North America and Europe ranked Agilent Compliance Services as their top choice for general laboratory compliance services and instrument qualification.
Agilent has consistently held this position every year the independent survey has been conducted since 1995, during which it has made more than 100,000 successful qualification deliveries.
Qualification of laboratory instrumentation is an integral part of compliance with regulatory and quality standards such as Good Manufacturing Practice, Good Laboratory Practice, ISO17025, and United States Pharmacopeia.
“When you seek out a compliance partner, the experience of other customers is a good predictor of the satisfaction you will receive,” said Gary Powers, Agilent SSD Compliance Program manager. “Especially when a lab has instruments from multiple manufacturers, achieving compliance can be a time-sink and a paperwork nightmare. An experienced compliance partner is an asset that can help overcome these challenges, reduce the costs of compliance, and avoid the risk of failed audits.”
Agilent Technologies
Agilent has consistently held this position every year the independent survey has been conducted since 1995, during which it has made more than 100,000 successful qualification deliveries.
Qualification of laboratory instrumentation is an integral part of compliance with regulatory and quality standards such as Good Manufacturing Practice, Good Laboratory Practice, ISO17025, and United States Pharmacopeia.
“When you seek out a compliance partner, the experience of other customers is a good predictor of the satisfaction you will receive,” said Gary Powers, Agilent SSD Compliance Program manager. “Especially when a lab has instruments from multiple manufacturers, achieving compliance can be a time-sink and a paperwork nightmare. An experienced compliance partner is an asset that can help overcome these challenges, reduce the costs of compliance, and avoid the risk of failed audits.”
Agilent Technologies
Friday, 25 February 2011
Agilent Technologies’ NMR Spectrometer chosen by Harvard Medical School Laboratory
Agilent Technologies Inc today announced that Harvard Medical School has selected Agilent’s 700-MHz Ultra-High Field Nuclear Magnetic Resonance (NMR) spectrometer for biomolecular research applications.
The spectrometer will be used by the laboratories of Drs Gerhard Wagner and James Chou of the Harvard Medical School to study protein structure and interaction.
The spectrometer will be used by the laboratories of Drs Gerhard Wagner and James Chou of the Harvard Medical School to study protein structure and interaction.
Thursday, 3 February 2011
Co-market agreement for Bioanalyzer and Pippin Prep DNA Systems
Agilent Technologies Inc and Sage Science Inc announced yesterday that they have signed a co-marketing agreement involving Agilent’s 2100 Bioanalyzer, used for the detection and quantification of nucleic acids, and Sage’s Pippin Prep DNA size-selection system.
The agreement between Sage and Agilent includes the copromotion of the respective products and development of application studies that will leverage the synergies of the two systems for next-generation sequencing applications.
“We are very pleased to be working with Agilent; our companies’ products are clearly complementary for the size-selection steps in next-generation sequencing,” said Gary Magnant, Sage CEO. “The high sensitivity of the 2100 Bioanalyzer kits provides superb analysis of DNA size distributions, with minimal sample consumption.”
Proper preparation and quality control of the input sample, as well as the library, are essential to achieving high-fidelity data in the next-generation sequencing workflow. The Pippin Prep, which automates DNA size selection for creating libraries, together with Agilent’s 2100 Bioanalyzer, the market-leading tool for sample and library quality control, advances and streamlines sample preparation.
“The Pippin Prep instrument from Sage and Agilent’s Bioanalyzer together offer a synergistic set of tools that enable researchers working with next-generation sequencing platforms to advance their research faster and more efficiently,” said Knut Wintergerst, electrophoresis marketing and support manager, Agilent.
Sage Science
Agilent Technologies
The agreement between Sage and Agilent includes the copromotion of the respective products and development of application studies that will leverage the synergies of the two systems for next-generation sequencing applications.
“We are very pleased to be working with Agilent; our companies’ products are clearly complementary for the size-selection steps in next-generation sequencing,” said Gary Magnant, Sage CEO. “The high sensitivity of the 2100 Bioanalyzer kits provides superb analysis of DNA size distributions, with minimal sample consumption.”
Proper preparation and quality control of the input sample, as well as the library, are essential to achieving high-fidelity data in the next-generation sequencing workflow. The Pippin Prep, which automates DNA size selection for creating libraries, together with Agilent’s 2100 Bioanalyzer, the market-leading tool for sample and library quality control, advances and streamlines sample preparation.
“The Pippin Prep instrument from Sage and Agilent’s Bioanalyzer together offer a synergistic set of tools that enable researchers working with next-generation sequencing platforms to advance their research faster and more efficiently,” said Knut Wintergerst, electrophoresis marketing and support manager, Agilent.
Sage Science
Agilent Technologies
Monday, 8 November 2010
Collaboration to advance burgeoning discipline of biologically inspired engineering
Agilent Technologies Inc and the Wyss Institute for Biologically Inspired Engineering at Harvard University today announced an agreement to work together to develop innovative tools, technologies and instruments that will advance human health and improve the environment.
“Agilent is very pleased to collaborate with the Wyss Institute as we share a strong commitment to innovation, interdisciplinary contribution, and high-impact research,” said Darlene Solomon, Agilent chief technology officer. “Wyss offers access to visionary researchers and physicians collaborating on enabling technology platforms to address some of the world’s most significant technological and societal challenges.”
“Agilent is very pleased to collaborate with the Wyss Institute as we share a strong commitment to innovation, interdisciplinary contribution, and high-impact research,” said Darlene Solomon, Agilent chief technology officer. “Wyss offers access to visionary researchers and physicians collaborating on enabling technology platforms to address some of the world’s most significant technological and societal challenges.”
Thursday, 4 November 2010
Target enrichment system with next-generation sequencing sample preparation
Agilent Technologies Inc has launched the Agilent SureSelect XT Target Enrichment System. SureSelect XT combines sequencing library preparation and gDNA preparative reagents with the proven SureSelect target enrichment system.
Target enrichment streamlines workflows by letting researchers sequence just the genomic regions of interest rather than entire genomes. Combined with the increasing capacity of the leading next-generation sequencers, the multiplexing support capabilities of the SureSelect XT platform make it possible for geneticists to interrogate the genome of more samples per study than previously possible. One of the rate-limiting steps in such studies has been library preparation and target enrichment. To enable high-throughput sample processing efficiency, Agilent has now released an integrated workstation that automates SureSelect XT library preparation and target enrichment workflows.
Target enrichment streamlines workflows by letting researchers sequence just the genomic regions of interest rather than entire genomes. Combined with the increasing capacity of the leading next-generation sequencers, the multiplexing support capabilities of the SureSelect XT platform make it possible for geneticists to interrogate the genome of more samples per study than previously possible. One of the rate-limiting steps in such studies has been library preparation and target enrichment. To enable high-throughput sample processing efficiency, Agilent has now released an integrated workstation that automates SureSelect XT library preparation and target enrichment workflows.
Tuesday, 12 October 2010
Combining CGH and SNP assays on same microarray, creates a unique cytogenetics tool
Agilent Technologies Inc today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
This is the only two-colour CGH platform that can detect loss of heterozygosity/uniparental disomy (LOH/UPD) with 5- to 10-megabase resolution.
This is the only two-colour CGH platform that can detect loss of heterozygosity/uniparental disomy (LOH/UPD) with 5- to 10-megabase resolution.
Thursday, 2 September 2010
Agilent Technologies ships 300th X-Ray Crystallography System
Agilent Technologies Inc today announced that it has shipped the 300th X-ray crystallography SuperNova system. The system was manufactured by Oxford Diffraction Ltd, part of Varian, Inc, which was acquired by Agilent in May, 2010.
Subscribe to:
Posts (Atom)